Pharmacological data on a new anti-inflammatory agent: 4-phenyl- -methylphenylacetate- -propylsulfonate sodium salt (6-137).
D000311:Adrenal Glands / Q000187:drug effects; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D007958:Leukocyte Count; D008297:Male; D010648:Phenylacetates / Q000009:adverse effects / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013270:Stomach / Q000187:drug effects; D013276:Stomach Ulcer / Q000139:chemically induced; D013451:Sulfonic Acids / Q000009:adverse effects / Q000494:pharmacology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D013451:Sulfonic Acids